NCT02242279View on ClinicalTrials.gov

Study to Evaluate Efficacy and Safety of Inhaled BEA 2180 BR in COPD Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

December 31, 2004

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

BEA 2180 BR

DRUG

Tiotropium

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY